Document is current
Any future updates will be listed below
-
Authors
Ayebare, A. https://orcid.org/0000-0002-1755-745X
Bebell, L. M.
Bazira, J.
Ttendo, S.
Katawera, V.
Bangsberg, D. R.
Siedner, M. J.
Firth, P. G.
Boum II, Y.
-
Funding
Funding for this research was provided by:
Center for Clinical and Translational Science, University of Massachusetts (KL2 TR001100)
Foundation for the National Institutes of Health (MH K23099916)
Kirschstein National Research Service Award (5T32AI007433-22)
- License Information
-
More Information
Article History
Received: 9 November 2018
Accepted: 5 August 2019
First Online: 22 August 2019
Ethics approval and consent to participate
: The study was approved by the institutional ethics review boards at Mbarara University of Science and Technology (No. 16/11–13 on March 6, 2014), Partners Healthcare (2014P000638 on June 16, 2014), and the Uganda National Council of Science and Technology.All participants provided written informed consent to participate in the study.
: All participants provided written informed consent for their data to be disseminated, including publication in peer-reviewed journals.
: Cepheid donated the Cepheid Xpert SA Nasal Complete assays for use in this study, and Life Science donated the Hain GenoQuick MRSA kits used in this study. All authors declare no other competing interests.
